Skip to main content
Log in

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies

  • Statistics
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

The planning and execution of clinical trials utilizing response-adaptive randomization is logistically complex. While a standardized approach to such designs is worthwhile, there are also unique challenges with each trial. Three detailed case studies are provided to illustrate the types of logistical issues that arise, as well as the decision problems coming before the data monitoring committees. Several lessons learned from these case studies are presented. These range from consideration of more extreme scenarios for trial simulation during the planning stage to formal establishment of an executive steering committee to facilitate the decision process (even for learn-phase trials).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fardipour P, Littman C, Burns D. et al. Planning and executing response-adaptive learn-phase clinical trials: 1. The process. Drug Inf J 2009;43:713–723.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parvin Fardipour PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fardipour, P., Littman, G., Burns, D.D. et al. Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies. Ther Innov Regul Sci 43, 725–734 (2009). https://doi.org/10.1177/009286150904300610

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150904300610

Key Words

Navigation